GDYN 最新10-Q变化
将 GDYN 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-10-30 与上一份 10-Q · 2026-07-30
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +13 | −14 | ~30 | 45 |
| 市场风险(第3项) | 文字有新增/删除 | 0 | 0 | ~14 | 4 |
| 控制与程序 | 文字有新增/删除 | +2 | −1 | ~1 | 1 |
| 法律诉讼 | 无段落级文字变化 | 0 | 0 | 0 | 1 |
| 风险因素 | 无段落级文字变化 | 0 | 0 | 0 | 2 |
| 其他信息 | 文字有新增/删除 | +2 | 0 | ~1 | 0 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-10-30
Our total revenues grew by 9.7% and 6.8%, reaching $114.3 million and $326.6 million for the three and nine months of 2026, respectively, compared to $104.2 million and $305.7 million in the prior-year periods, primarily driven by our TMT vertical.
Retail contributed 27.2% and 26.8% of our total revenues for the three and nine months ended September 30, 2026, respectively. Revenues for the third quarter grew by $3.7 million, or 13.3%, reaching $31.1 million, compared to $27.4 million in the prior-year quarter. The growth was primarily driven b…
The Finance vertical contributed 22.5% and 22.9% of total revenues for the three and nine months ended September 30, 2026, respectively. Revenues remained relatively flat on a quarterly basis, reaching $25.7 million for the three months ended September 30, 2026, compared to $25.6 million in the prio…
September 30, 2025. Strong demand from our banking and financial services customers was offset by the completion of engagements at certain insurance customers.
The Consumer Packaged Goods/Manufacturing (“CPG/Manufacturing”) accounted for 10.9% and 11.0% of total revenues for the three and nine months ended September 30, 2026, respectively. Revenues were flat at $12.5 million compared to the prior-year quarter. Growth from a leading wholesale food distribut…
相对上期删除的文字 · 来源:10-Q · 2026-07-30
Our total revenues grew by 7.0% and 5.3%, reaching $108.2 million and $212.3 million for the three and six months of 2026, respectively.
Retail contributed 26.5% and 26.6% of our total revenues for three and six months ended June 30, 2026. Revenues reached $28.6 million for the second quarter and $56.4 million for the year-to-date period, versus $28.8 million and $60.0 million, respectively, in the prior year periods. Within this ver…
Finance revenues experienced decreases of 2.6% and 2.4%, reaching $24.7 million and $49.2 million, for the three and six months ended June 30, 2026, compared to $25.4 million and $50.4 million for the same periods in the prior year. Within this vertical strong demand from our banking and financial s…
The Consumer Packaged Goods/Manufacturing (“CPG”) accounted for 10.9% and 11.0% of total revenues for the three and six months ended June 30, 2026, respectively. Revenues in this vertical remained relatively flat on a quarterly basis reaching $11.8 million and $11.3 million for the three months ende…
•Healthcare and Pharma generated $2.1 million and $4.3 million of revenues for the three and six months ended June 30, 2026, representing 1.9% and 2.0% of total revenues, respectively. This compares to $2.6 million and $5.0 million, or 2.5% of total revenues in both periods of 2025.
控制与程序
相对上期新增的文字 · 来源:10-Q · 2026-10-30
timely basis, information required to be disclosed by us in the reports that we file or submit under the Exchange Act and were effective in ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our man…
Our management, including the Chief Executive Officer and Chief Financial Officer, confirmed there have been no changes in our internal control over financial reporting during the three months ended September 30, 2026, that have materially affected, or are reasonably likely to materially affect, our…
相对上期删除的文字 · 来源:10-Q · 2026-07-30
Our management, including the Chief Executive Officer and Chief Financial Officer, confirmed there have been no changes in our internal control over financial reporting during the three months ended June 30, 2026, that have materially affected, or are reasonably likely to materially affect, our inte…
其他信息
相对上期新增的文字 · 来源:10-Q · 2026-10-30
On August 3, 2026, Leonard Livschitz, our Chief Executive Officer and a Director, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of up to 994,787 shares of our common stock. The trading arrangement was intended to satisfy the affirmative defense under Rule 10b5-1(…
On August 26, 2026, Anil Doradla, our Chief Financial Officer, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of up to 243,308 shares of our common stock. The trading arrangement was intended to satisfy the affirmative defense under Rule 10b5-1(c) under the Securi…
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议